and/or

33 Blog posts found

Feature

T Is for T Cell: The Science Behind Immunotherapy

By deciphering the biology of T cells, MSK scientists gave immunotherapy a boost.

T cells on the loose.

Q&A

New Approach Could Boost Immunotherapy for Breast Cancer

A protein on certain immune cells is a promising target for making immunotherapy more effective against breast cancer.

Illustration of immune cell opening as if on hinge and boxing glove coming out.

In the Lab

Resistance Is Futile: Targeted Treatment Makes Stubborn Cancers Responsive to Immunotherapy

New research on an experimental drug provides hope for better responses to immunotherapy.

A chess match

Feature

Do Cancer Vaccines Have a Shot at Success?

After a string of failures, therapeutic cancer vaccines have acquired something of a bad rap. Can we do better?

Needle entering a vaccine vial.

Snapshot

T Cell Attack: Taking Down Cancer with Immunotherapy

MSK physician-scientist Prasad Adusumilli is focused on developing more-effective immunotherapy approaches for treating tumors in the chest.

Cell Therapy and Cell Engineering Facility

Finding

Gene Discovery Could Lead to More-Personalized Treatment with Immunotherapy

Researchers have found two gene mutations that many exceptional responders to ipilimumab have in common.

Nadeem Riaz and Timothy Chan

In the News

Symposium Held at MSK Honors Alexander Rudensky, Pioneering Immunologist

One of MSK’s leading immunologists turned 60 on Friday, and scientists came to celebrate.

Announcement

News from #AACR16: Precision Medicine Progress, Turbocharged CARs, and Turning Up the Heat against Cancer

At the 2016 American Association for Cancer Research (AACR) conference, there were clear signs that cancer treatment is evolving from a slash-and-burn method to a more precisely targeted, intelligent approach.

José Baselga

Announcement

News from #AACR16: Targeted Therapy Breakthrough, Improved Survival in Melanoma, and Benefits of Gut Bugs

Long-awaited results of clinical trials testing targeted drugs and immunotherapy combinations were on offer at the annual American Association for Cancer Research (AACR) conference.

Dr. Joan Massagué, Sloan Kettering Institute Director received the Pezcoller Foundation-AACR International Award for Cancer Research and was named an AACR fellow at AACR16.

In the Lab

In the Fight against Cancer, the Immune System Can Be a Double-Edged Sword

The immune system is a powerful tool for fighting cancer — sometimes too powerful.

photo of Foxo1 protein stained in regulatory T cells